Thomaspartners’s GSK GSK Stock Holding History

Thomaspartners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,265	Closed	-$246K	–	128
2015 Q1	$246K	Sell	4,265 -112	-3%	-$6.42K	﹤0.01%	115
2014 Q4	$234K	Hold	4,377	–	–	﹤0.01%	119
2014 Q3	$252K	Hold	4,377	–	–	﹤0.01%	120
2014 Q2	$293K	Sell	4,377 -301	-6%	-$20.4K	0.01%	109
2014 Q1	$312K	Sell	4,678 -484	-9%	-$32.7K	0.01%	111
2013 Q4	$344K	Sell	5,162 -112	-2%	-$7.26K	0.01%	111
2013 Q3	$331K	Sell	5,274 -584	-10%	-$37.6K	0.01%	108
2013 Q2	$366K	Buy	+5,858	New	+$372K	0.01%	110

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thomaspartners's GSK Position: Q2 2015 in Review

Thomaspartners sold out of GSK (GSK) in Q2 2015, closing a stake of 4,265 shares — an estimated $246K sold.

Thomaspartners first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $366K in Q2 2013. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Thomaspartners reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
Thomaspartners sold 4,265 GSK shares in Q2 2015, an estimated $246K.
Thomaspartners first reported a position in GSK in Q2 2013 and held it in 8 quarters.
Thomaspartners's GSK position peaked at $366K in Q2 2013.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Thomaspartners's 13F filing for Q2 2015, filed 17 Aug 2015.